Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations.
Researchers used molecular techniques to investigate the interactions between apolipoprotein E4 (ApoE4) and cinnamon-derived compounds for developing effective diagnostic strategies and treatment for Alzheimer's disease (AD). Epicatechin was found to have the highest binding affinity to ApoE4 by forming strong hydrogen bonds with specific residues. Adding a hydroxyl group to epicatechin increased its binding affinity to ApoE4, indicating promising therapeutic candidates for AD.
- Shaji D et al (2023).
- Biophys Chem.
- PubMed:
- 36898350